About Caponex Labs
Caponex Labs is a company based in Hyderabad (India) founded in 2020 by S Madi Reddy. Caponex Labs has raised $278.67 thousand across 1 funding round from investors including Balvinder Singh Thakkar and Ravinder Singh Thakkar. The company has 1 employees. Caponex Labs operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Headquarter Hyderabad, India
- Employees 1
- Founders S Madi Reddy
- SectorsChemicals & MaterialsHealthcare
- Email••••••••
- Phone•••• ••••
- Website caponexlabs.com
- Social LinkedIn
- Legal Name Caponex Labs Private Limited
- Date of Incorporation 08 Aug, 2020
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹15.72 Cr
FY 2025 · +133% YoY
- Net Profit₹5.49 Cr
FY 2025 · 35% margin
- EBITDA₹5.44 Cr
FY 2025 · 35% margin
- Total Equity Funding$278.67K (USD)
in 1 rounds
- Latest Funding Round$278.67K (USD), Angel Round
Mar 2023
- Employee Count1
Associated legal entities of Caponex Labs
Caponex Labs operates through Caponex Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Caponex Labs Private Limited CIN U73100TG2020PTC142637 | Active | 08 Aug 2020 | Hyderabad, Telangana | ₹15.7 Cr | 64 | 2 | View details |
Funding Insights of Caponex Labs
Caponex Labs has successfully raised a total of $278.67K through 1 strategic funding round. The most recent funding activity was a Angel Round of $278.67 thousand completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $278,668
- Total Rounds 1
- Last Round Angel Round — $278,668
- First Round $278,668
(Mar 2023)
- Investors Count 2
All 1 funding rounds of Caponex Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | $278,668 | Angel Round | – | Balvinder Singh Thakkar, Ravinder Singh Thakkar | – |
2 investors in total: 0 institutional and 2 angel.
Investors in Caponex Labs
Caponex Labs has secured backing from 2 investors, including angel investors. Prominent investors backing the company include Balvinder Singh Thakkar and Ravinder Singh Thakkar.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
BS Balvinder Singh Thakkar | - | – | unknown_f4f9ed4a2b414e7e8 | - |
RS Ravinder Singh Thakkar | - | – | unknown_b49e2156eb6d46d09 | - |
Investor details for Caponex Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Caponex Labs Private Limited (Caponex Labs)
Caponex Labs Private Limited is the primary company behind Caponex Labs. The board of Caponex Labs Private Limited currently have 2 directors; the longest-serving is Srinivasa Rao Madireddy, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Srinivasa Rao Madireddy DIN 07676752 | Director | 08 Aug 2020 | 6 yrs 2 mo | Caponex Labs Private Limited |
| Deepika Madireddy DIN 08827236 | Director | 08 Aug 2020 | 6 yrs 2 mo | Caponex Labs Private Limited |
People of Caponex Labs
1 people are tracked at Caponex Labs (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
S Madi Reddy | Founder & Managing Director | Leadership |
Complete people profiles for Caponex Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Caponex Labs
Figures of Caponex Labs Private Limited, the primary company behind Caponex Labs, for FY 2025. Revenue was ₹15.72 Cr (+133% year on year). Net profit was ₹5.49 Cr (35% margin). EBITDA was ₹5.44 Cr (35% margin). Revenue has grown at a compounded annual rate of +298% over three years.
- ₹15.72 CrRevenue · FY 2025 · +133% YoY
- ₹5.49 CrNet profit · 35% margin
- ₹5.44 CrEBITDA · 35% margin
- ₹9.99 CrPaid-up capital
- 64Employees (provident fund records)
- +298%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Caponex Labs Private Limited are on its company page.
Detailed financial statements for Caponex Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Caponex Labs
2 dated milestones of Caponex Labs across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Caponex Labs is founded.
- Funding First funding round of $279K.
Competitors of Caponex Labs
Caponex Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pharmaron.com | 2003 | Beijing, China | $320M | 476 | Drug discovery and development services for small molecules are provided. | |
| lonza.com | 1897 | Basel, Switzerland | $100,000 | 14,500 | CDMO services for pharma, biotech, and specialty ingredients are provided. | |
| pfizer.com | 1849 | New York, United States | $8M | – | Pharmaceutical products for treating multiple diseases are provided. | |
| boehringer-ingelheim.com | 1885 | – | – | 31 | Generic drugs and clinical research services are provided globally. | |
| labconnect.com | 2002 | Johnson, United States | $28.5M | – | Laboratory testing, clinical trial research, and biopharma services are provided. | |
| dotmatics.com | 2005 | – | $11.34M | 512 | AI powered scientific data management and workflow automation solutions | |
| ainos.com | 1986 | San Diego, United States | – | 43 | Novel point-of-care testing and low-dose interferon therapeutics are developed. | |
| biomatter.ai | 2018 | Vilnius, Lithuania | $7.73M | – | Provider of synthetic biology and AI-based technology for generative protein design | |
| betadrugslimited.com | 2005 | Panchkula, India | – | 637 | Developer of therapeutics for oncology and dermatology |
Detailed competitors of Caponex Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Caponex Labs
10 companies that operate in the same segment as Caponex Labs (Chemical Services), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Bulk liquid chemicals are transported and stored by the conglomerate. | 1959 | London, England, United Kingdom | – | USD 2.85 B | – | |
Titanium dioxide pigments are manufactured using sulfate and chloride processes. | – | – | – | – | – | |
Carbon Recycling International is recognized as a leader in CO2 to methanol technology. | 2006 | Kopavogur, Iceland | USD 30 M | – | – | |
Specialty chemical manufacturing, research, and services across multiple industries. | 2023 | Bengaluru, Karnataka, India | – | USD 2.13 M | – | |
Chemical products are distributed and services provided to various sectors. | 2004 | Runcorn, Cheshire, United Kingdom | – | – | – | |
Professional cleaning services are provided by Christeyns to various sectors. | 1946 | Ghent, East Flanders, Belgium | – | – | 12 | |
Security solutions for currency, brands, and identity are provided. | 1927 | Prilly, Vaud, Switzerland | – | – | – | |
Construction engineering and design services are offered worldwide. | 1953 | Beijing, China | – | USD 27.12 B | 51,000 | |
PVC and plastic products are manufactured and traded. | 2021 | Delhi, Delhi, India | – | USD 53.18 M | 6 | |
Product development, supplier management, metrology, and engineering services are provided. | 2019 | Harvard, Illinois, United States | USD 32 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Caponex Labs
Caponex Labs was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Caponex Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Caponex Labs is a funded company, having raised a total of $278.67K across 1 funding round to date. The company's 1st funding round was a Angel Round of $278.67K, raised on Mar 2023.
Caponex Labs has 1 employees.
The primary company behind Caponex Labs, Caponex Labs Private Limited, reported revenue of ₹15.72 Cr for FY 2025, up 133% year on year.
Caponex Labs was established in 2020 in Hyderabad, India, within the pharmaceutical analytical services sector. Analytical method development, validation, quality control, and formulation analysis are offered, encompassing microbiological studies, release testing, trace metal analysis, impurity profiling, dissolution profiles, extractable analysis, physicochemical characterization, and stability testing. Operations adhere to safety and regulatory standards across these areas.
Caponex Labs has 2 investors. Key investors include Balvinder Singh Thakkar, and Ravinder Singh Thakkar.
Caponex Labs operates through Caponex Labs Private Limited.
The legal entities of Caponex Labs currently have 2 directors, including Srinivasa Rao Madireddy, Deepika Madireddy.